Home
About us
Clinical Research
- Chronic obstructive pulmonary disease (COPD)
- Asthma
Production
- PMBL
- Symbiofilm®
Products
Respiratory Health
Worldwide partners
Partners Area
Contact us

Lallemand Pharma

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Lallemand Pharma

Home
About us
Clinical Research
- Chronic obstructive pulmonary disease (COPD)
- Asthma
Production
- PMBL
- Symbiofilm®
Products
Respiratory Health
Worldwide partners
Partners Area
Contact us

EN
- English
- Español
- русский

Lallemand Pharma
Figure-3_21-percentage-s-pneumoniae-non-susceptible-macrolides-2015

News details

Sep
7,
2017

Figure-3_21-percentage-s-pneumoniae-non-susceptible-macrolides-2015

Sep 7, 2017

Respire
Inspire!

Respiratory Health

Clinical Research

Home
About us

Clinical Research
- Chronic obstructive pulmonary disease (COPD)
- Asthma
Production

Products
Respiratory Health

Worldwide partners
Partners Area
Contact us
Terms and conditions
Cookie and privacy policy

LALLEMAND Inc.
is a privately held Canadian company, founded at the end of the 19th century, specializing in the development, production, and marketing of yeasts and bacteria

© 2024 Lallemand Inc. All right reserved

Authentication required

Username or Email Password

Forgot your password? Create an account